2991 - 3000 of 8808 Results
Title
Year
- DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s disease2024OPENTitle: DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-024-00421-0Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-024-00421-0Citation Count: 7
-
OPENTitle: Mechanism of human PINK1 activation at the TOM complex in a reconstituted systemJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.adn7191Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.adn7191?download=trueCitation Count: 18
- Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's disease2021OPENTitle: Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 1Start Page: 23End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2021.11.006Best OA location URL: https://doi.org/10.1016/j.brs.2021.11.006Citation Count: 6
-
OPENTitle: Protective Factors That Maintain Asymptomatic Longevity in Untreated Congenitally Corrected Transposition of Great ArteriesJournal Name: CJC OpenPublisher: Elsevier BVVol: 4Issue #: 3Start Page: 355End Page: 355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cjco.2021.11.004Best OA location URL: http://www.cjcopen.ca/article/S2589790X21003012/pdfCitation Count: 0
-
OPENTitle: Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over timeJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100126End Page: 100126Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100126Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100126Citation Count: 2
-
OPENTitle: Evaluation of morning bradykinesia in Parkinson’s disease in a United States cohort using continuous objective monitoringJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 6Issue #:Start Page: 100145End Page: 100145Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100145Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100145Citation Count: 8
-
OPENTitle: Structure–Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1H-indoles as Tauopathy Positron Emission Tomography RadiotracersJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c02988Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c02988?ref=article_openPDFCitation Count: 3
-
OPENTitle: Neuromelanin-sensitive MRI correlates of cognitive and motor function in Parkinson's disease with freezing of gaitJournal Name: Frontiers in DementiaPublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/frdem.2023.1215505Best OA location URL: https://www.frontiersin.org/articles/10.3389/frdem.2023.1215505/pdfCitation Count: 5
-
OPENTitle: Fluorescence microscopy shadow imaging for neuroscienceJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fncel.2024.1330100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2024.1330100/pdf?isPublishedV2=FalseCitation Count: 2
-
OPENTitle: Why Therapeutic Trials Fail in Primary TauopathiesJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 545End Page: 550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29322Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10398638/pdf/nihms-1915318.pdfCitation Count: 5